APVO
Price
$3.24
Change
-$0.22 (-6.36%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
2.46M
GNPX
Price
$0.23
Change
-$0.02 (-8.00%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
6.56M
Interact to see
Advertisement

APVO vs GNPX

Header iconAPVO vs GNPX Comparison
Open Charts APVO vs GNPXBanner chart's image
Aptevo Therapeutics
Price$3.24
Change-$0.22 (-6.36%)
VolumeN/A
Capitalization2.46M
Genprex
Price$0.23
Change-$0.02 (-8.00%)
Volume$27.2K
Capitalization6.56M
APVO vs GNPX Comparison Chart in %
Loading...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APVO vs. GNPX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APVO is a Buy and GNPX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (APVO: $3.46 vs. GNPX: $0.25)
Brand notoriety: APVO and GNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APVO: 16% vs. GNPX: 176%
Market capitalization -- APVO: $2.46M vs. GNPX: $6.56M
APVO [@Biotechnology] is valued at $2.46M. GNPX’s [@Biotechnology] market capitalization is $6.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APVO’s FA Score shows that 0 FA rating(s) are green whileGNPX’s FA Score has 0 green FA rating(s).

  • APVO’s FA Score: 0 green, 5 red.
  • GNPX’s FA Score: 0 green, 5 red.
According to our system of comparison, APVO is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APVO’s TA Score shows that 4 TA indicator(s) are bullish while GNPX’s TA Score has 4 bullish TA indicator(s).

  • APVO’s TA Score: 4 bullish, 3 bearish.
  • GNPX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, APVO is a better buy in the short-term than GNPX.

Price Growth

APVO (@Biotechnology) experienced а +22.70% price change this week, while GNPX (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

APVO is expected to report earnings on May 15, 2025.

GNPX is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNPX($6.56M) has a higher market cap than APVO($2.46M). GNPX YTD gains are higher at: -70.643 vs. APVO (-95.986). GNPX has higher annual earnings (EBITDA): -19.14M vs. APVO (-23.79M). GNPX has more cash in the bank: 3.47M vs. APVO (2.14M). GNPX has less debt than APVO: GNPX (279K) vs APVO (4.42M). APVO (0) and GNPX (0) have equivalent revenues.
APVOGNPXAPVO / GNPX
Capitalization2.46M6.56M38%
EBITDA-23.79M-19.14M124%
Gain YTD-95.986-70.643136%
P/E Ratio0.00N/A-
Revenue00-
Total Cash2.14M3.47M62%
Total Debt4.42M279K1,585%
FUNDAMENTALS RATINGS
APVO vs GNPX: Fundamental Ratings
APVO
GNPX
OUTLOOK RATING
1..100
9454
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9895
P/E GROWTH RATING
1..100
58100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APVO's Valuation (50) in the Biotechnology industry is in the same range as GNPX (50) in the Pharmaceuticals Major industry. This means that APVO’s stock grew similarly to GNPX’s over the last 12 months.

APVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that APVO’s stock grew similarly to GNPX’s over the last 12 months.

APVO's SMR Rating (100) in the Biotechnology industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that APVO’s stock grew similarly to GNPX’s over the last 12 months.

GNPX's Price Growth Rating (95) in the Pharmaceuticals Major industry is in the same range as APVO (98) in the Biotechnology industry. This means that GNPX’s stock grew similarly to APVO’s over the last 12 months.

APVO's P/E Growth Rating (58) in the Biotechnology industry is somewhat better than the same rating for GNPX (100) in the Pharmaceuticals Major industry. This means that APVO’s stock grew somewhat faster than GNPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APVOGNPX
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
76%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPW4.500.06
+1.35%
Medical Properties Trust
VTRS8.950.10
+1.13%
Viatris
APM0.97N/A
-0.01%
Aptorum Group Limited
BFIN11.50-0.02
-0.17%
BankFinancial Corp
ABUS3.37-0.04
-1.17%
Arbutus Biopharma Corp

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with GOSS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
+6.46%
GOSS - APVO
42%
Loosely correlated
+0.73%
ENLV - APVO
39%
Loosely correlated
+2.59%
AXON - APVO
33%
Loosely correlated
+1.41%
GNPX - APVO
30%
Poorly correlated
+9.17%
KROS - APVO
29%
Poorly correlated
-0.36%
More

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
+9.17%
REVB - GNPX
48%
Loosely correlated
+12.40%
HOWL - GNPX
37%
Loosely correlated
N/A
AXON - GNPX
30%
Poorly correlated
+1.41%
TYRA - GNPX
30%
Poorly correlated
+0.31%
APVO - GNPX
30%
Poorly correlated
+6.46%
More